Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain

Synapse

Volumn 64, Issue 7, 2010, Pages 573-577

  Finnema, S J ^a   Varrone, A ^a   Hwang, T J ^a,d   Gulyas B ^a   Pierson, M E ^b   Halldin, C ^a   Farde, L ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

5 HT1B; PET; Primate brain; Radioligand; Serotonin release

Indexed keywords

AZ 10419369; CARBON 11; FENFLURAMINE; RADIOLIGAND; SEROTONIN 1B RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; DOSE RESPONSE; DRUG SENSITIVITY; EXPERIMENTAL MONKEY; LIGAND BINDING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RECEPTOR BINDING; SEROTONIN RELEASE;

ANIMALS; BENZOPYRANS; BRAIN; CARBON RADIOISOTOPES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENFLURAMINE; MACACA FASCICULARIS; MORPHOLINES; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN; SEROTONIN AGENTS; TIME FACTORS;

EID: 77953860552     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20780     Document Type: Article

References (24)

1. Aznavour N, Rbah L, Riad M, Reilhac A, Costes N, Descarries L, Zimmer L. 2006. A PET imaging study of 5-HT(1A) receptors in cat brain after acute and chronic fluoxetine treatment. Neuroimage 33:834-842.
2. Derry C, Benjamin C, Bladin P, le Bars D, Tochon-Danguy H, Berkovic SF, Zimmer L, Costes N, Mulligan R, Reutens D. 2006. Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy. Neuroimage 30: 341-348.
3. Engel G, Gothert M, Hoyer D, Schlicker E, Hillenbrand K. 1986. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn Schmiedebergs Arch Pharmacol 332:1-7. (Pubitemid 16149704)
4. Göthert M, Schlicker E, Fink K, Classen K. 1987. Effects of RU 24969 on serotonin release in rat brain cortex: Further support for the identity of serotonin autoreceptors with 5-HT1B sites. Arch Int Pharmacodyn Ther 288:31-42. (Pubitemid 17134784)
5. Hume S, Hirani E, Opacka-Juffry J, Myers R, Townsend C, Pike V, Grasby P. 2001. Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine. Synapse 41:150-159.
6. Janoshazi A, Deraet M, Callebert J, Setola V, Guenther S, Saubamea B, Manivet P, Launay JM, Maroteaux L. 2007. Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors. Mol Pharmacol 71:1463-1474.
7. Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T, Brooks DJ, Bench CJ, Grasby PM. 1998. Evidence for striatal dopamine release during a video game. Nature 393:266-268.
8. Laruelle M. 2000. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423-451. (Pubitemid 30164887)
9. Maeda J, Suhara T, Ogawa M, Okauchi T, Kawabe K, Zhang MR, Semba J, Suzuki K. 2001. In vivo binding properties of [carbonyl-11C]WAY-100635: Effect of endogenous serotonin. Synapse 40: 122-129.
10. Maura G, Roccatagliata E, Raiteri M. 1986. Serotonin autoreceptor in rat hippocampus: Pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn Schmiedebergs Arch Pharmacol 334:323-326.
11. Mennini T, Bizzi A, Caccia S, Codegoni A, Fracasso C, Frittoli E, Guiso G, Padura IM, Taddei C, Uslenghi A, Garattini S. 1991. Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs. Naunyn Schmiedebergs Arch Pharmacol 343:483-490.
12. Mukaida K, Shichino T, Koyanagi S, Himukashi S, Fukuda K. 2007. Activity of the serotonergic system during isoflurane anesthesia. Anesth Analg 104:836-839.
13. Pierson ME, Andersson J, Nyberg S, McCarthy DJ, Finnema SJ, Varnas K, Takano A, Karlsson P, Gulyas B, Medd AM, Lee CM, Powell ME, Heys JR, Potts W, Seneca N, Mrzljak L, Farde L, Halldin C. 2008. [11C]AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain. Neuroimage 41:1075-1085.
14. Praschak-Rieder N, Hussey D, Wilson AA, Carella A, Lee M, Dunn E, Willeit M, Bagby RM, Houle S, Meyer JH. 2004. Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: An [(18)F] MPPF positron emission tomography study. Biol Psychiatry 56:587-591.
15. Sayer TJ, Hannon SD, Redfern PH, Martin KF. 1999. Diurnal variation in 5-HT1B autoreceptor function in the anterior hypothalamus in vivo: Effect of chronic antidepressant drug treatment. Br J Pharmacol 126:1777-1784.
16. Sibon I, Benkelfat C, Gravel P, Aznavour N, Costes N, Mzengeza S, Booij L, Baker G, Soucy JP, Zimmer L, Descarries L. 2008. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers. Biol Psychiatry 63:1135-1140.
17. Tomasi G, Nabulsi N, Weinzimmer D, Sandiego C, Gallezot JD, Wang E, McLean S, Huang Y, Ding Y, Carson RE. 2008. In vivo Scatchard analysis of bolus/infusion 5-HT1B studies with [11C]P943: Comparison between SRTM and equilibrium methods. NeuroImage 41:T16.
18. Udo de Haes JI, Bosker FJ, Van Waarde A, Pruim J, Willemsen AT, Vaalburg W, Den Boer JA. 2002. 5-HT(1A) receptor imaging in the human brain: Effect of tryptophan depletion and infusion on [(18)F]MPPF binding. Synapse 46:108-115.
19. Udo de Haes JI, Harada N, Elsinga PH, Maguire RP, Tsukada H. 2006. Effect of fenfluramine-induced increases in serotonin release on [18F]MPPF binding: A continuous infusion PET study in conscious monkeys. Synapse 59:18-26.
20. Varnäs K, Hall H, Bonaventure P, Sedvall G. 2001. Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [H]GR 125743. Brain Res 915:47-57.
21. Varrone A, Sjoholm N, Eriksson L, Gulyas B, Halldin C, Farde L. 2009. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur J Nucl Med Mol Imaging 36:1639-1650.
22. Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R, Burr G, Cooper T, Wolf AP. 1994. Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 16:255-262. (Pubitemid 24111524)
23. Zimmer L, Mauger G, Le Bars D, Bonmarchand G, Luxen A, Pujol JF. 2002. Effect of endogenous serotonin on the binding of the 5-hT1A PET ligand 18F-MPPF in the rat hippocampus: Kinetic beta measurements combined with microdialysis. J Neurochem 80:278-286.
24. Zimmer L, Rbah L, Giacomelli F, Le Bars D, Renaud B. 2003. A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18FMPPF binding in the rat hippocampus. J Nucl Med 44:1495-1501. (Pubitemid 39663366)